scholarly article | Q13442814 |
P50 | author | Vincenzo Arcoraci | Q47436348 |
Luigi Cardia | Q61141495 | ||
Gioacchino Calapai | Q37368499 | ||
P2093 | author name string | Carmen Mannucci | |
Cristina Mondello | |||
Epifanio Mondello | |||
Martina Di Pietro | |||
Raffaella Mallamace | |||
Domenico Quattrone | |||
Giuseppe Bova | |||
Alessia A Barbagallo | |||
P2860 | cites work | Anterior lumbar interbody fusion for treatment of failed back surgery syndrome: an outcome analysis | Q79792106 |
Failed back surgery syndrome | Q83778363 | ||
Cannabis, Cannabinoids, and Sleep: a Review of the Literature | Q39204199 | ||
Long-term outcome of patients treated with spinal cord stimulation for therapeutically refractory failed back surgery syndrome: a retrospective study | Q39259581 | ||
Cannabis use for chronic non-cancer pain: results of a prospective survey | Q39397282 | ||
The neuropathic components of chronic low back pain: a prospective multicenter study using the DN4 Questionnaire | Q39725622 | ||
Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation | Q42053693 | ||
Treatment of chronic pain by using intrathecal drug therapy compared with conventional pain therapies: a cost-effectiveness analysis | Q44197494 | ||
Mindfulness-based stress reduction for failed back surgery syndrome: a randomized controlled trial. | Q48327875 | ||
The Epidemiology of Chronic Pain of Predominantly Neuropathic Origin. Results From a General Population Survey | Q21710682 | ||
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities | Q24623282 | ||
Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials | Q24625489 | ||
The orphan receptor GPR55 is a novel cannabinoid receptor | Q24670137 | ||
Failed back surgery syndrome: current perspectives | Q28070035 | ||
Etiologies of failed back surgery syndrome | Q28257647 | ||
Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors | Q28298326 | ||
Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review | Q28300877 | ||
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide | Q28362078 | ||
Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement | Q28394506 | ||
Guidelines for the use of cannabinoid compounds in chronic pain | Q33225562 | ||
Surgery versus prolonged conservative treatment for sciatica. | Q34004463 | ||
Spinal Cord Stimulation vs. Conventional Medical Management: A Prospective, Randomized, Controlled, Multicenter Study of Patients with Failed Back Surgery Syndrome (PROCESS Study). | Q34029717 | ||
The evidence for pharmacological treatment of neuropathic pain | Q34130946 | ||
Agonistic properties of cannabidiol at 5-HT1a receptors | Q34463976 | ||
Using confirmatory factor analysis to evaluate construct validity of the Brief Pain Inventory (BPI). | Q34709065 | ||
Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism | Q34714609 | ||
Failed back surgery syndrome - definition, epidemiology and demographics | Q36110581 | ||
Persistent postsurgical pain: risk factors and prevention | Q36477806 | ||
Delta(9)-tetrahydrocannabinol, 11-hydroxy-delta(9)-tetrahydrocannabinol and 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids | Q36555572 | ||
Neurostimulation technology for the treatment of chronic pain: a focus on spinal cord stimulation | Q36759518 | ||
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? | Q38012845 | ||
Interventional pain management for failed back surgery syndrome | Q38078503 | ||
Pharmacotherapy of neuropathic pain: which drugs, which treatment algorithms? | Q38383817 | ||
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials | Q38386497 | ||
The endocannabinoid system and neuropathic pain | Q38702807 | ||
Neurological Aspects of Medical Use of Cannabidiol | Q38835253 | ||
Recent strategies for drug development in fibromyalgia syndrome | Q38881756 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cannabinoids | Q422936 |
P304 | page(s) | 1761-1767 | |
P577 | publication date | 2018-01-01 | |
P1433 | published in | Journal of Pain Research | Q6295704 |
P1476 | title | Cannabinoids and spinal cord stimulation for the treatment of failed back surgery syndrome refractory pain | |
P478 | volume | 11 |
Q95270490 | A Balanced Approach for Cannabidiol Use in Chronic Pain | cites work | P2860 |
Search more.